InvestorsHub Logo
Followers 664
Posts 46990
Boards Moderated 1
Alias Born 03/30/2009

Re: None

Thursday, 12/13/2012 9:59:13 AM

Thursday, December 13, 2012 9:59:13 AM

Post# of 48316
Here's part of today's news; people seem to be getting in at a pps below the "exercise price" (see bolded text below).

SAN DIEGO, Dec. 13, 2012 /PRNewswire/ -- OncoSec Medical Inc. (OTCBB: ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat solid tumor cancers, announced today that it has entered into definitive agreements with institutional investors to purchase approximately $7.2 million of securities in a registered public offering. OncoSec has agreed to sell to institutional investors an aggregate of 28,800,000 shares of its common stock at $0.25 per share. Additionally, investors will receive warrants to purchase up to 14,400,000 shares of common stock at an exercise price of $0.26 per share for a term of four years.


For the complete PR, click this link:

http://ih.advfn.com/p.php?pid=nmona&article=55448319&symbol=ONCS

$ONCS

Success is never final; failure is never fatal. It's courage that counts.--John Wooden (1910-2010)

Courage is being scared to death, but saddling up anyway.--John Wayne (1907-1979)